PlantArc Bio Ltd. (TLV:PLNT)
Israel · Delayed Price · Currency is ILS · Price in ILA 202.50
-2.10 (-1.03%)
Oct 5, 2025, 3:49 PM IDT
PlantArc Bio Market Cap
PlantArc Bio has a market cap or net worth of 6.71 million as of October 7, 2025. Its market cap has decreased by -45.03% in one year.
Market Cap
6.71M
Enterprise Value
-1.00M
Revenue
3.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
202.50
Market Cap Chart
Since January 7, 2021, PlantArc Bio's market cap has decreased from 54.46M to 6.71M, a decrease of -87.67%. That is a compound annual growth rate of -35.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2025 | 6.71M | -35.55% |
| Dec 31, 2024 | 10.42M | -6.55% |
| Dec 31, 2023 | 11.15M | -57.45% |
| Dec 29, 2022 | 26.20M | 5.28% |
| Dec 30, 2021 | 24.89M | -54.31% |
| Jan 7, 2021 | 54.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 75.93B |
| Danel (Adir Yeoshua) | 3.00B |
| Kamada | 1.33B |
| Bait Bakfar | 974.87M |
| BrainsWay | 961.20M |
| SofWave Medical | 943.38M |
| Ilex Medical | 714.47M |
| Novolog (Pharm-Up 1966) | 661.07M |